• Medicine
  • Published in Nature Reviews Drug Discovery 2003
  • DOI:10.1038/nrd989

The further evolution of biotech

@article{Nagle2003TheFE,
  title={The further evolution of biotech},
  author={Tricia Nagle and Carilee Berg and Rena Nassr and Kevin Pang},
  journal={Nature Reviews Drug Discovery},
  year={2003},
  volume={2},
  pages={75-79}
}
Born 20 years ago with the launch of recombinant insulin, the biotechnology industry is maturing, with several leading companies now rivalling traditional pharmaceutical companies in many ways. What might the next 20 years hold for biotech-based drug development? 

Figures, Tables, and Topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.
SHOWING 1-10 OF 14 CITATIONS

Challenges in commercializing stem cells and regenerative medicine technologies: A case study on dedicated biotech firms in Japan

  • 2013 Proceedings of PICMET '13: Technology Management in the IT-Driven Services (PICMET)
  • 2013
VIEW 2 EXCERPTS
CITES BACKGROUND